← Back to headlines
Merck Transforms Through Acquisitions Ahead of Keytruda Patent Expiry
Pharmaceutical giant Merck is undergoing a transformation driven by strategic acquisitions as it prepares for the upcoming patent expiration of its top-selling cancer drug, Keytruda.
14 Apr, 10:00 — 14 Apr, 10:00
Sources
Showing 1 of 1 sources
Related Stories
Europe Records Over 35,000 Excess Deaths from Heatwaves
23m ago
HSE Agrees to Fund Friedreich's Ataxia Drug in Ireland
54m ago
No West Nile Virus Cases Reported in FBiH, Public Health Director Urges Preparedness
1h ago
Critical Heat Measurements in Vienna Senior Apartments Prompt Calls for Subsidized Air Conditioning
1h ago